Skip to main content

Day: April 11, 2022

Magnetic North Acquisition Corp. Announces Non-Brokered Private Placement of Up to $1 Million

**Not for distribution to United States Newswire Services or release publication, distribution or dissemination, directly or indirectly, in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities Laws** CALGARY, Alberta and TORONTO, April 11, 2022 (GLOBE NEWSWIRE) — Magnetic North Acquisition Corp. (TSXV: MNC) (“Magnetic North” or the “Company”) is pleased to announce a planned non-brokered private placement (the “Financing”) for gross proceeds of up to approximately $1,000,008.00 CAD. The Financing consists of up to 105,264 Units at $9.50 per Unit. Each Unit is comprised of one Series A Preferred Share ‎(“Series A Preferred Shares‎”) and one Series A Preferred Share purchase warrant (“Warrant”) for gross proceeds of up to $1,000,008.00 CAD. Each Warrant will entitle the holder...

Continue reading

Dundee Precious Announces First Quarter 2022 Preliminary Production Results

TORONTO, April 11, 2022 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announced preliminary production results from both of its mines and smelter for the three months ended March 31, 2022. The Company confirmed that all operations are on track to meet previously issued guidance for 2022. “The first quarter was a solid start to the year, with production at Chelopech and Ada Tepe in-line with guidance,” said David Rae, President and Chief Executive Officer. “At the end of March, we also announced an optimized life of mine plan for Chelopech, which resulted in higher gold and copper production, and an extended mine life to 2030.” Production Highlights Preliminary results for the first quarter are provided in the table below:  Ore processed Metals contained in concentrate produced Payable metals...

Continue reading

Purple Biotech Presents Positive Interim Phase 1b Study Results for CM24 at the American Association of Cancer Research 2022 Annual Meeting

First-in-class monoclonal antibody in combination with Opdivo® (nivolumab) demonstrates strong safety and an initial efficacy profile for PDAC REHOVOT, Israel, April 11, 2022 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech”, or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance today announced favorable safety and efficacy data supporting the advancement of CM24, a first-in-class clinical stage monoclonal antibody with the potential to treat multiple solid tumor cancers. Data from the Phase 1b study of CM24 in combination with Opdivo® (nivolumab) is being presented in a poster entitled “Interim Safety and Efficacy Results from a Phase 1b Study of CM24 in Combination with Nivolumab...

Continue reading

Fluence Announces Agreement to Acquire AI-Enabled Software-as-a-Service Company Nispera

In increasingly sophisticated energy markets, forecast of granular asset availability, production profile, and management becomes imperative for value capture Enhances Fluence’s digital leadership position with a combined digital portfolio of 15 GW contracted or under management Accelerates development and roll-out of new applications on Fluence IQ Digital Platform Strengthens foundation for recurring revenue and expected to be EBITDA accretive by 2024ARLINGTON, Va., April 11, 2022 (GLOBE NEWSWIRE) — Fluence (NASDAQ: FLNC), a leading global provider of energy storage products, services and digital applications for renewables and storage, announced today that it has entered into an agreement to acquire Nispera AG (Nispera). Nispera is a Zurich-based provider of artificial intelligence (AI) and machine learning-enabled software-as-a-service...

Continue reading

Diffusion Pharmaceuticals Completes Dosing in Altitude Trial

Topline data expected within two months Blinded, interim data to be presented at the Undersea & Hyperbaric Medical Society’s Annual Scientific Meeting in May 2022 CHARLOTTESVILLE, Va., April 11, 2022 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced the final participant has completed dosing in its Altitude Trial. The Altitude Trial is a double-blind, randomized, placebo-controlled crossover study, designed to evaluate the effects of TSC on maximal oxygen consumption, or VO2, and partial pressure of arterial blood oxygen, or PaO2, in normal healthy volunteers subjected to incremental levels of physical exertion while exposed...

Continue reading

Notice of Annual General Meeting in Eolus Vind AB (publ)

Hässleholm, Sweden, April 11th, 2022 The shareholders of Eolus Vind AB (publ) Reg. No. 556389-3956 are hereby invited to attend the Annual General Meeting (“AGM”) to be held on May 19, 2022 at 2 p.m. CEST in Kulturhuset in Hässleholm, Vattugatan 18. Registration for the AGM begins at 1.30 p.m. CEST. The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the AGM also by postal voting in accordance with the regulations in Eolus’ Articles of Association. Right to participate Participation in the meeting room A) Anyone wishing to attend the meeting room in person or through a representative must be recorded as a shareholder in the share register maintained by Euroclear Sweden AB, made as of May 11, 2022, and no later than May 13, 2022 preferably before 4 p.m. CEST, notify the company of their...

Continue reading

Europe CRO Services Market Size [2022-2029] worth USD 35.91 Billion | exhibiting a CAGR of 9.0%

Europe CRO Services Market Covered By Key Companies – Pharmaceutical Product Development, LLC Medpace Holdings, Inc. (U.S.), Parexel International Corporation (Ireland), IQVIA , Laboratory Corporation of American Holdings (U.S.), Charles River Laboratories, PHASTAR , Oy 4Pharma Ltd , PSI Pune, India, April 11, 2022 (GLOBE NEWSWIRE) — The Europe CRO services market size was USD 16.97 billion in 2021. The market is projected to grow from USD 19.68 billion in 2022 to USD 35.91 billion by 2029, exhibiting a CAGR of 9.0% during the forecast period. This information is published by Fortune Business Insights™, in its report titled, “Europe CRO Services Market, 2022-2029”. Speedy technological progressions and rising urbanization in European nations are motivating numerous biotech and pharmaceutical corporations to subcontract their...

Continue reading

STEYR recognized as Red Dot Design Award winner for Terrus CVT tractor

STEYR_Terrus_CVT_Red_ DotThe Red Dot Design Award, one of the world’s largest design competitions, has recognized the STEYR Terrus CVT tractor as a winner in the Product Design category. The Red Dot Label has become established internationally as one of the most sought-after marks of quality for good design. London, April 11, 2022 STEYR, a regional agricultural brand of CNH Industrial (NYSE: CNHI / MI: CNHI), has been awarded the prestigious 2022 Red Dot Design Award for its Terrus CVT Tractor, the latest in a series of accolades for this vehicle. The award is determined by an international design jury who, this year, evaluated a record number of international entries from companies and design studios. As a winner in the Product Design category, the Terrus CVT will feature in the next edition of the Red Dot Design Yearbook and will...

Continue reading

Wires and Cables Market Size Worth USD 294.73 Billion, Globally, by 2029 at 5.7% CAGR: Fortune Business Insights™

Wires and Cables companies mentioned in report are Prysmian Group, Southwire Company, Nexans, Furukawa Electric, Fujikura, Sumitomo Corporation, Belden, LS Cable & System, KEI Industries, Cords Cable Industries, NKT A/S, Amphenol, Finolex Cables, Polycab, Encore Wire Corp. Pune, India, April 11, 2022 (GLOBE NEWSWIRE) — The global wires and cables market size is projected to reach USD 294.73 billion in 2029 from USD 200.23 billion in 2022 and exhibit a CAGR of 5.7% during the forecast period. The global wires and cables market size stood at USD 181.28 billion in 2021. The rising demand for renewable energy generation, coupled with growing investments in distribution and transmission of electric power are expected to amplify the market growth. Fortune Business Insights has presented this information in its report titled, Wires...

Continue reading

Point of care Diagnostics Market Size [2022-2028] worth USD 36.21 Billion | Increasing Prevalence of Chronic Disorders to Boost Market Growth

Prominent Players Covered in the Point of Care Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics Incorporated, BD, bioMérieux SA, Cardinal Health, Inc, Mesa Biotech, Cepheid, Trinity Biotech, Quidel Corporation, Bio-Rad Laboratories Inc., and other key market players Pune, India, April 11, 2022 (GLOBE NEWSWIRE) — The global point of care diagnostics market size is projected to reach USD 36.21 billion by 2028, exhibiting a CAGR of -1.9% during the forecast period. The prevalence of several chronic disorders and the incorporation of nanotechnology in diagnostic kits are likely to fuel market growth. Fortune Business Insights™ provides this information in its report titled “Point of care Diagnostics Market, 2022-2028.” The occurrence of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.